Literature DB >> 9803460

Suppression of sigma spindle electroencephalographic activity as a measure of transient arousal after spontaneous and occlusion-evoked sighs and startles.

H Wulbrand1, F McNamara, B T Thach.   

Abstract

Defective arousal mechanisms are viewed as contributory to sleep hypopnea disorders and sudden infant death syndrome. Sighs (i.e. augmented breaths) as well as startles have not traditionally been viewed as arousal-related phenomena in infants. We hypothesized that, if sighs and startles are the initial event in a sequential arousal process, then they might be associated with specific EEG activity changes, because activation of the arousal-related ascending reticular activating system can suppress thalamus-generated sigma spindle oscillations. We studied spontaneous sighs and startles and those elicited by briefly occluding the infants face mask airway in 12 normal infants (age 10-19 wk) during non-rapid eye movement sleep. We recorded EEG (C3-P3), ECG, O2 saturation, diaphragmatic electromyography, limb electromyography, and video of the infant. The startle intensity was scored on a scale of 0 to 3 based on video recorded movements. Sleep spindle periodicity was analyzed by using a threshold over a compressed spectral band array. Spontaneous sighs and sleep startles were immediately followed by an interspindle interval prolongation from (mean +/- SEM) 8.0 +/- 0.16 s (control period) to 17.9 +/- 1.45 s after spontaneous sighs, to 23.8 +/- 1.26 s after spontaneous sighs accompanied by startles and to 26.5 +/- 1.45 s after occlusion-related sighs and startles. Furthermore, the intensity of occlusion-evoked startles was positively correlated with the interspindle interval prolongation (p < 0.01). We conclude that spontaneous as well as evoked sighs and startles are immediately followed by a transient sleep spindle suppression. This phenomenon indicates a close linkage between sighs, startles, and reticular formation-related arousal mechanisms.

Entities:  

Mesh:

Year:  1998        PMID: 9803460     DOI: 10.1203/00006450-199811000-00021

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

Review 1.  Obstructive sleep apnea in infants.

Authors:  Eliot S Katz; Ron B Mitchell; Carolyn M D'Ambrosio
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

2.  Sleeping position and electrocortical activity in low birthweight infants.

Authors:  R Sahni; K F Schulze; S Kashyap; K Ohira-Kist; W P Fifer; M M Myers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-27       Impact factor: 5.747

3.  Spontaneous arousal activity in infants during NREM and REM sleep.

Authors:  Frances McNamara; Anna S Lijowska; Bradley T Thach
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

Review 4.  Central and peripheral factors contributing to obstructive sleep apneas.

Authors:  Jan-Marino Ramirez; Alfredo J Garcia; Tatiana M Anderson; Jenna E Koschnitzky; Ying-Jie Peng; Ganesh K Kumar; Nanduri R Prabhakar
Journal:  Respir Physiol Neurobiol       Date:  2013-06-11       Impact factor: 1.931

Review 5.  The integrative role of the sigh in psychology, physiology, pathology, and neurobiology.

Authors:  Jan-Marino Ramirez
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

6.  The role of arousal related brainstem reflexes in causing recovery from upper airway occlusion in infants.

Authors:  Henning Wulbrand; Frances McNamara; Bradley T Thach
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

7.  Activation of opioid micro-receptors in medullary raphe depresses sighs.

Authors:  Zhenxiong Zhang; Fadi Xu; Cancan Zhang; Xiaomin Liang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-25       Impact factor: 3.619

8.  How to score arousals in preterm infants? Can we use recommendations of the Pediatric Wake-up Club?

Authors:  Heinz Zotter; Berndt Urlesberger; Wilhelm Müller; Reinhold Kerbl
Journal:  Wien Klin Wochenschr       Date:  2003-12-30       Impact factor: 2.275

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.